Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Interleukin-2 receptor alfa chaina expression in patients with alopecia areata (CROSBI ID 109178)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Brajac, Ines ; Gruber, Franjo ; Petrovečki, Mladen ; Malnar Dragojević, Daniela Interleukin-2 receptor alfa chaina expression in patients with alopecia areata // Acta Dermatovenerologica Croatica, 12 (2004), 3; 154-156-x

Podaci o odgovornosti

Brajac, Ines ; Gruber, Franjo ; Petrovečki, Mladen ; Malnar Dragojević, Daniela

engleski

Interleukin-2 receptor alfa chaina expression in patients with alopecia areata

Interleukin-2 (IL-2) is a lymphokine produced by activated T-cells. Its receptor, IL-2R, is expressed on T-cells. Several clinical and experimental findings point towards IL-2 as a crucial mediator inducing immunologic reaction against human follicle in alopecia areata. The objective of our study was to analyze the expression of IL-2R as a sign of T-cell activation in scalp biopsies of patients suffering from alopecia areata. An immunohistochemical analysis was used to determine the difference in cytokine-regulated expression of IL-2R between 45 patients with active and stable phase of alopecia areata and 23 healthy control subjects. In the patients with alopecia areata in active phase, the expression of IL-2R in scalp biopsies was significantly stronger than that in the patients with stable disease and in controls. The increase of IL-2R+ cells in early phase of the disease could suggest that T-lymphocyte activation with IL-2 secretion and IL-2R expression may initiate the immune inflammatory mechanism of alopecia areata

Interleukin 2 receptor; alopecia areata

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

12 (3)

2004.

154-156-x

objavljeno

1330-027X

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost